Your CDMO for Small Molecule Drug Substance Manufacturing
As a leading contract development and manufacturing organization (CDMO), Evonik offers the confidence and expertise you need to tackle complex drug development and manufacturing challenges. Partnering with us means gaining access to a global network of services and deep technical know-how.
Evonik is one of the world’s largest CDMOs, with core strengths in chemistry, engineering, and biotechnology. Our proven track record is built on quality, supply security, and a strong commitment to sustainability. With our business-for-business (B4B) philosophy, we focus on shared success - supporting companies of all sizes through purposeful collaboration and a commitment to long-term partnerships.
We believe great science is built on strong relationships. Our customers trust us because we take the time to understand their challenges and deliver solutions that stand up to real‑world pressure. Your molecule becomes our mission, and we take that responsibility personally.
Head of drug substance product line
Your technology experts for API & intermediate manufacturing
For over 20 years, Evonik has supported customers with innovator-focused HPAPI projects and complex API processes. Our robust manufacturing network delivers APIs, HPAPIs, and intermediates—from clinical trial quantities to large-scale commercial volumes. Whether your project is small or highly complex, we offer reliable, high-quality production with a sustainable supply chain.
Our differentiating technologies: Excellence from process development to commercial scale
We offer a highly differentiated portfolio of technologies to support even the most complex syntheses of APIs, HPAPIs, and intermediates. Our flexible solutions span the entire development lifecycle—from early-stage process development to full-scale commercial manufacturing.
Leveraging deep expertise in chemical innovation and advanced engineering, we tailor our approach to meet specialized requirements with precision, safety, and scalability.
Our integrated capabilities include:
| Technology | Description | Download |
|---|---|---|
| Catalysis & Biocatalysis | From catalyst screening to scale-up, including recycling via organic solvent nanofiltration. | Download flyer |
| Microbial fermentation | Supporting biotechnological production routes | Download flyer |
| Continuous processing | Enhancing efficiency and safety for high-energy reactions. | |
| Chemistry in water | Sustainable synthesis using micellar catalysis in aqueous media | |
| Advanced processes | Download flyer | |
| Chiral chemistry | Download flyer | |
| Cryogenic chemistry | Including one of the world’s largest GMP cryogenic capacities | |
| Particle engineering & Crystallization | Optimizing purity, stability, and performance | |
| Chromatography | From ultra-HPAPI small-scale GMP to commercial-scale purification | Download flyer |
Our technologies are designed to meet the growing demand for efficient, safe, and sustainable manufacturing of high-potency and complex molecules. Through continuous investment in state-of-the-art facilities and novel process technologies, we empower pharmaceutical innovators to advance their pipelines with confidence and agility.
Our locations
Our sites in Europe, the U.S. and China have capacities from lab-scale through to small, medium or large-scale production:
Take the first step to tackling your complex drug development and manufacturing challenges. Get in touch!
